LON:SPH Sinclair Pharma (SPH) Share Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free SPH Stock Alerts GBX 31.80 0.00 (0.00%) (As of 11/5/2018) Add Compare Share Share Today's Range 31.80▼ 31.8050-Day Range 31.80▼ 31.8052-Week Range 14.45▼ 32Volume373,221 shsAverage Volume3.30 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sinclair Pharma alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Sinclair Pharma Stock (LON:SPH)Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.Read More SPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SPH Stock News HeadlinesApril 15, 2024 | yahoo.com'Respect it': Sinclair police cadets, DDN reporter get taste of pepper sprayFebruary 28, 2024 | msn.comSinclair Broadcast GAAP EPS of -$5.35 misses by $5.86, revenue of $826M misses by $14.63MApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.February 10, 2024 | health.usnews.comCheryl SinclairJanuary 23, 2024 | health.usnews.comDr. Robert SinclairDecember 17, 2023 | seekingalpha.comSinclair Continues To Face ChallengesSeptember 22, 2023 | health.usnews.comPRISCILLA A. SINCLAIRAugust 12, 2023 | health.usnews.comChristine A. SinclairApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.August 1, 2023 | health.usnews.comDr. William R. SinclairJuly 21, 2023 | health.usnews.comDr. Peter SinclairMay 10, 2023 | health.usnews.comTiffany SinclairMarch 25, 2023 | health.usnews.comDr. Cassandra S. SinclairFebruary 22, 2023 | finance.yahoo.comGlobal Cosmetic Surgery Market Report 2022: Featuring Candela, Allergan, Merz Pharma, Mentor Worldwide, Lumenis, Sinclair Pharma & CuteraJanuary 12, 2023 | yahoo.comWho Is Olivia Colman’s Husband, Ed Sinclair? Here’s Everything We KnowSeptember 14, 2022 | uk.news.yahoo.comTrevor Sinclair deletes Twitter account after asking why 'black and brown' people should mourn QueenAugust 4, 2022 | finance.yahoo.comSinclair Reports Second Quarter 2022 Financial ResultsJune 29, 2022 | finance.yahoo.comSinclair (SBGI) Upgraded to Buy: What Does It Mean for the Stock?May 18, 2022 | finance.yahoo.comSinclair Pharma Partners with Vanguard Aesthetics to Launch Silhouette Soft in MalaysiaMarch 18, 2022 | lse.co.ukSinclair Pharma Share ChatSee More Headlines Receive SPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Major Sub-IndustryN/A Current SymbolLON:SPH CUSIPN/A CIKN/A Webwww.sinclairispharma.com Phone+44-20-74676920FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Christopher P. SpoonerCEO & Exec. DirectorMr. Alan Musgrave Olby (Age 47)CFO & Director Ms. Jayne Burrell (Age 43)Group Gen. Counsel & Company Sec. Ms. Emilie CroissantHead of Europe & Global MarketingMr. Nairn McMasterHead of Latin AmericaKey CompetitorsAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNPremaitha HealthLON:NIPTSummit TherapeuticsLON:SUMMView All Competitors SPH Stock Analysis - Frequently Asked Questions How have SPH shares performed in 2024? Sinclair Pharma's stock was trading at GBX 31.80 on January 1st, 2024. Since then, SPH shares have increased by 0.0% and is now trading at GBX 31.80. View the best growth stocks for 2024 here. What other stocks do shareholders of Sinclair Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sinclair Pharma investors own include Vectura Group (VEC), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), ASOS (ASC), Cracker Barrel Old Country Store (CBRL), Jack in the Box (JACK). How do I buy shares of Sinclair Pharma? Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SPH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinclair Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
